5-硝基-2-甲氧基-1-异丙苯 | 1706-81-6

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 5-硝基-2-甲氧基-1-异丙苯
• 英文名称: 2-Isopropyl-1-methoxy-4-nitro-benzene
• 英文别名: 5-Nitro-2-methoxy-1-isopropyl-benzol；2-Isopropyl-1-methoxy-4-nitrobenzene；1-methoxy-4-nitro-2-propan-2-ylbenzene
• CAS: 1706-81-6
• 化学式: C₁₀H₁₃NO₃
• mdl: MFCD09030064
• 分子量: 195.218
• InChiKey: CFNOXOUAIAUFMI-UHFFFAOYSA-N

物化性质

• 沸点：
  295.7±33.0 °C(Predicted)
• 密度：
  1.113±0.06 g/cm3(Predicted)
• 溶解度：
  氯仿（微溶）、乙酸乙酯（微溶）

计算性质

• 辛醇/水分配系数(LogP)：
  2.8
• 重原子数：
  14
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.4
• 拓扑面积：
  55
• 氢给体数：
  0
• 氢受体数：
  3

安全信息

• 海关编码：
  2909309090

反应信息

• 作为反应物：
  描述：

  5-硝基-2-甲氧基-1-异丙苯 在 盐酸 、 tin 、 四氯化锡 、 二乙胺 作用下， 反应 5.08h， 生成 2-methoxy-3-isopropyl-7,8,9,10-tetrahydrophenanthridine
  参考文献：
  名称：

  Compounds from Danshen. Part 4. Structure-activity relationship of miltirone, an active central benzodiazepine receptor ligand isolated from Salvia miltiorrhiza Bunge (Danshen)

  摘要：

  Twenty one o-quinonoid-type compounds and one coumarin-type compound related to miltirone (1) have been synthesized with the aim to identify the key structural elements involved in miltirone's interaction with the central benzodiazepine receptor. On the basis of their inhibition of [H-3]flunitrazepam binding to bovine cerebral cortex membranes, it is apparent that ring A of miltirone is essential for affinity. Although increasing the size of ring A from six-membered to seven- and eight-membered is well-tolerated, the introduction of polar hydroxyl groups greatly reduces binding affinity. The presence of 1,1-dimethyl groups on ring A is, however, not essential. On the other hand, the isopropyl group on ring C appears to be critical for binding as its removal decreases affinity by more than 30-fold. It can, however, be replaced with a methyl group with minimal reduction in affinity. Finally, linking ring A and B with a -CH2CH2- bridge results in analogue 89, which is 6 times more potent than miltirone at the central benzodiazepine receptor (IC50 = 0.05-mu-M).

  DOI：

  10.1021/jm00109a022
• 作为产物：
  描述：

  2-异丙基苯甲醚 在 硝酸 作用下， 以68%的产率得到5-硝基-2-甲氧基-1-异丙苯
  参考文献：
  名称：

  Compounds from Danshen. Part 4. Structure-activity relationship of miltirone, an active central benzodiazepine receptor ligand isolated from Salvia miltiorrhiza Bunge (Danshen)

  摘要：

  Twenty one o-quinonoid-type compounds and one coumarin-type compound related to miltirone (1) have been synthesized with the aim to identify the key structural elements involved in miltirone's interaction with the central benzodiazepine receptor. On the basis of their inhibition of [H-3]flunitrazepam binding to bovine cerebral cortex membranes, it is apparent that ring A of miltirone is essential for affinity. Although increasing the size of ring A from six-membered to seven- and eight-membered is well-tolerated, the introduction of polar hydroxyl groups greatly reduces binding affinity. The presence of 1,1-dimethyl groups on ring A is, however, not essential. On the other hand, the isopropyl group on ring C appears to be critical for binding as its removal decreases affinity by more than 30-fold. It can, however, be replaced with a methyl group with minimal reduction in affinity. Finally, linking ring A and B with a -CH2CH2- bridge results in analogue 89, which is 6 times more potent than miltirone at the central benzodiazepine receptor (IC50 = 0.05-mu-M).

  DOI：

  10.1021/jm00109a022

文献信息

• Diaminopyrimidines as P2X3 and P2X2/3 modulators
  申请人：Dillon Patrick Michael

  公开号：US20070049610A1

  公开（公告）日：2007-03-01

  Compounds of the formula I: or pharmaceutically acceptable salts thereof, wherein A, D, E, G, J, X, Y, Z R 6 , R 7 and R 8 are as defined herein. Also provided are methods of using the compounds for treating diseases mediated by a P2X 3 and/or a P2X 2/3 receptor antagonist and methods of making the compounds.

  化合物的结构式I：或其药用可接受的盐，其中A、D、E、G、J、X、Y、Z、R6、R7和R8的定义如本文所述。还提供了使用这些化合物治疗由P2X3和/或P2X2/3受体拮抗剂介导的疾病的方法，以及制备这些化合物的方法。
• COMPOUNDS USEFUL FOR INHIBITING CHK1
  申请人：Keegan Kathleen S.

  公开号：US20100105683A1

  公开（公告）日：2010-04-29

  Aryl- and heteroaryl-substituted urea compounds useful in the treatment of diseases and conditions related to DNA damage or lesions in DNA replication are disclosed. Methods of making the compounds, and their use as therapeutic agents, for example, in treating cancer and other diseases characterized by defects in DNA replication, chromosome segregation, or cell division also are disclosed.

  本发明公开了用于治疗与DNA损伤或DNA复制中的损伤有关的疾病和病症的芳基和杂环基取代脲化合物。本发明还公开了制备该化合物的方法以及它们作为治疗剂的用途，例如，在治疗癌症和其他以DNA复制缺陷、染色体分离或细胞分裂为特征的疾病中。
• Thyromimetics. I. The Synthesis and Hypocholesteremic Activity of Some 3' and 3',5'-Alkyl and Aryl-3,5-diiodothyronines
  作者：Benjamin Blank、Francis R. Pfeiffer、Cyrus M. Greenberg、James F. Kerwin

  DOI：10.1021/jm00341a020

  日期：1963.9
• CHANG, HSON MOU;CHUI, KUK YING;TAN, FAN WAH LAU;YANG, YUN;ZHONG, ZENG PEI+, J. MED. CHEM., 34,(1991) N, C. 1675-1692
  作者：CHANG, HSON MOU、CHUI, KUK YING、TAN, FAN WAH LAU、YANG, YUN、ZHONG, ZENG PEI+

  DOI：——

  日期：——
• DIAMINOPYRIMIDINES AS P2X3 AND P3X2/3 MODULATORS
  申请人：F.Hoffmann-La Roche AG

  公开号：EP1924565B1

  公开（公告）日：2016-09-14